Brief Summary

This clinical trial studies the effectiveness of a group curriculum in improving survivorship outcomes in adolescent and young adult (AYA) cancer survivors. Many AYA survivors typically do not feel prepared to re-enter "daily life" and would likely benefit from structured interventions to offer education and support in a timely manner as to prepare them for the challenges of life in survivorship. A 6-week group curriculum, designed to specifically meet the needs of AYA cancer survivors and facilitated by licensed social workers, may meet the unique needs of young adults who have survived a cancer diagnosis, and if so, the curriculum could be licensed and used across Mayo Clinic sites and potentially at other cancer centers nationwide.

Trial Health

On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment

participants targeted

Target at P25-P50 for not_applicable

Timeline

18mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach

1 country

1 active site

Status

recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

4.8 years study duration

Study Progress70%

Jan 2023Oct 2027

First Submitted

Initial submission to the registry

October 11, 2022

Completed

7 days until next milestone

First Posted

Study publicly available on registry

October 18, 2022

Completed

3 months until next milestone

Study Start

First participant enrolled

January 16, 2023

Completed

4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2027

Expected

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2027

Last Updated

January 30, 2026

Status Verified

January 1, 2026

Enrollment Period

4.8 years

First QC Date

October 11, 2022

Last Update Submit

January 29, 2026

Conditions

Hematopoietic and Lymphoid System Neoplasm Malignant Solid Neoplasm

Outcome Measures

Primary Outcomes (1)

Change in quality of life
Will be measured using the Quality of Life Patient/Cancer Survivor Version (QOL-CSV). The QOL-CSV is based on pre-existing versions of the City of Hope's QOL instrument. A pilot study conducted by Hassey-Dow and Farrell provided data which resulted in the revision of the QOL into 41 items that represent four domains of quality of life as pertaining to cancer survivorship: physical, psychological, social, and spiritual well-being. Only the psychological well-being, social concerns, and spiritual well-being components will be used. A two-sided paired t-test for the difference in the mean response will be conducted. A significance level of 0.05 will be used. If the data violate normality assumptions, a non-parametric alternative will be used. Additional summary statistics such as the proportion of participants who reported an improvement in QOL-CSV score may be used as appropriate.
Baseline and 6 weeks

Secondary Outcomes (1)

Change in well-being
Baseline and 6 weeks

Study Arms (1)

Supportive Care (group curriculum)

EXPERIMENTAL

Participants attend an online group facilitated by two oncology social workers and receive information regarding coping with cancer survivorship as a young adult, as well as discuss survivorship issues/concerns with peers.

Other: CounselingProcedure: DiscussionOther: Informational InterventionOther: Medical Chart ReviewOther: Quality-of-Life AssessmentOther: Questionnaire Administration